• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轴向型脊柱关节炎的病理生理学:共识与争议。

Pathophysiology of axial spondyloarthritis: Consensus and controversies.

机构信息

Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands.

Walaeus Library, Leiden University Medical Center, Leiden, the Netherlands.

出版信息

Eur J Clin Invest. 2018 May;48(5):e12913. doi: 10.1111/eci.12913. Epub 2018 Mar 13.

DOI:10.1111/eci.12913
PMID:29460306
Abstract

BACKGROUND

Axial spondyloarthritis (axSpA) is a common inflammatory arthritis of the sacroiliac joints and the spine. The best-known and most studied form of axSpA is ankylosing spondylitis.

DESIGN

In this review, we provide a brief overview of the pathophysiology of axSpA. In addition, we performed a quantitative text analysis of reviews on the pathogenesis of axSpA published in the last 10 years to establish the current consensus in various fields of research into the pathogenesis of axSpA.

RESULTS

There appears to be broad consensus on genetic risk factors and the involvement of the immune system in the initiation phase of the disease although little consensus was found on which specific immune cells drive disease. Moreover, despite relatively little data available, alterations in the microbiome are commonly thought to be involved in disease. Abnormal bone formation is the most prominent pathogenic factor thought to be involved in disease progression.

CONCLUSION

So, although the pathophysiology of axSpA remains incompletely understood, the progress in recent years in several fields of research in axSpA including genetics, diagnosis, imaging and therapeutics, hold great promise for the future.

摘要

背景

中轴型脊柱关节炎(axSpA)是一种常见的累及骶髂关节和脊柱的炎性关节炎。在 axSpA 中,最广为人知和研究最多的形式是强直性脊柱炎。

设计

在这篇综述中,我们简要概述了 axSpA 的发病机制。此外,我们对过去 10 年中发表的关于 axSpA 发病机制的综述进行了定量文本分析,以确立 axSpA 发病机制各个研究领域的当前共识。

结果

尽管在哪些特定的免疫细胞驱动疾病方面尚未达成共识,但似乎在遗传风险因素和免疫系统参与疾病的起始阶段存在广泛共识。此外,尽管可用的数据相对较少,但微生物组的改变通常被认为与疾病有关。异常的骨形成被认为是参与疾病进展的最主要的致病因素。

结论

因此,尽管 axSpA 的发病机制仍不完全清楚,但近年来在 axSpA 的几个研究领域(包括遗传学、诊断、影像学和治疗学)取得的进展,为未来带来了巨大的希望。

相似文献

1
Pathophysiology of axial spondyloarthritis: Consensus and controversies.轴向型脊柱关节炎的病理生理学:共识与争议。
Eur J Clin Invest. 2018 May;48(5):e12913. doi: 10.1111/eci.12913. Epub 2018 Mar 13.
2
Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry.强直性脊柱炎与非放射学轴性脊柱关节炎:肿瘤坏死因子抑制剂疗效及HLA - B27状态影响的比较。一项来自全国性DANBIO注册研究的观察性队列研究。
J Rheumatol. 2017 Jan;44(1):59-69. doi: 10.3899/jrheum.160958. Epub 2016 Dec 1.
3
Referral strategies for early diagnosis of axial spondyloarthritis.轴性脊柱关节炎的早期诊断转诊策略。
Nat Rev Rheumatol. 2012 Apr 10;8(5):262-8. doi: 10.1038/nrrheum.2012.39.
4
Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort.骶髂关节结构损伤与轴性脊柱关节炎患者功能状态和脊柱活动度的相关性:来自德国脊柱关节炎起始队列的研究结果。
Arthritis Res Ther. 2017 Oct 24;19(1):240. doi: 10.1186/s13075-017-1453-3.
5
Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.新德里一家单一风湿病诊所中强直性脊柱炎(AS)患者与非放射学轴向脊柱关节炎(nr-axSpA)患者的比较。
Int J Rheum Dis. 2015 Sep;18(7):736-41. doi: 10.1111/1756-185X.12579. Epub 2015 Jul 14.
6
Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?非放射性轴性脊柱关节炎患者与强直性脊柱炎患者有何不同?
Arthritis Care Res (Hoboken). 2012 Sep;64(9):1415-22. doi: 10.1002/acr.21688.
7
Pathophysiology and immunolgical basis of axial spondyloarthritis.轴性脊柱关节炎的病理生理学和免疫学基础。
Best Pract Res Clin Rheumatol. 2023 Sep;37(3):101897. doi: 10.1016/j.berh.2023.101897. Epub 2023 Nov 28.
8
Looking through the window of opportunity in axial spondyloarthritis?在轴性脊柱关节炎中寻找机会之窗?
Joint Bone Spine. 2023 Dec;90(6):105603. doi: 10.1016/j.jbspin.2023.105603. Epub 2023 Jun 22.
9
Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis.强直性脊柱炎与非放射学中轴型脊柱关节炎外周及关节外疾病的患病率:一项荟萃分析。
Arthritis Res Ther. 2016 Sep 1;18(1):196. doi: 10.1186/s13075-016-1093-z.
10
Consensus statement on the investigation and management of non-radiographic axial spondyloarthritis (nr-axSpA).关于非放射学中轴型脊柱关节炎(nr-axSpA)调查与管理的共识声明。
Int J Rheum Dis. 2014 Jun;17(5):548-56. doi: 10.1111/1756-185X.12358. Epub 2014 Mar 28.

引用本文的文献

1
Diagnostic delay in patients from the International Map of Axial Spondyloarthritis: geographic, sociodemographic and disease-related factors.国际轴向型脊柱关节炎地图中患者的诊断延迟:地理、社会人口统计学和疾病相关因素
Rheumatology (Oxford). 2025 Apr 1;64(4):1873-1879. doi: 10.1093/rheumatology/keae521.
2
An Overview of Adalimumab Therapy for Ankylosing Spondylitis.阿达木单抗治疗强直性脊柱炎概述。
Curr Rheumatol Rev. 2024;20(5):501-513. doi: 10.2174/0115733971289295240223095751.
3
The Effects of Pilates Exercise Training Combined with Walking on Cardiorespiratory Fitness, Functional Capacity, and Disease Activity in Patients with Non-Radiologically Confirmed Axial Spondylitis.
普拉提运动训练结合步行对非放射学确诊的轴性脊柱关节炎患者心肺适能、功能能力及疾病活动度的影响
J Funct Morphol Kinesiol. 2023 Oct 4;8(4):140. doi: 10.3390/jfmk8040140.
4
Clinical profile and treatment utilisation based on HLA-B*27 status in axial spondyloarthritis: results from ASAS-PerSpA study.基于 HLA-B*27 状态的中轴型脊柱关节炎的临床特征和治疗利用情况:ASAS-PerSpA 研究结果。
RMD Open. 2023 Jul;9(3). doi: 10.1136/rmdopen-2023-003179.
5
Spondyloarthritis mass cytometry immuno-monitoring: a proof of concept study in the tight-control and treat-to target TiCoSpA trial.脊柱关节炎液基免疫监测质谱流式细胞术:在严格控制和达标治疗 TiCoSpA 试验中的概念验证研究。
Clin Rheumatol. 2023 Sep;42(9):2387-2396. doi: 10.1007/s10067-023-06637-1. Epub 2023 Jun 12.
6
Human Leukocyte Antigen B27-Negative Axial Spondyloarthritis: What Do We Know?人类白细胞抗原B27阴性的轴性脊柱关节炎:我们了解什么?
ACR Open Rheumatol. 2023 Jul;5(7):333-344. doi: 10.1002/acr2.11555. Epub 2023 May 24.
7
Uncovering the Underworld of Axial Spondyloarthritis.揭开中轴型脊柱关节炎的神秘面纱。
Int J Mol Sci. 2023 Mar 30;24(7):6463. doi: 10.3390/ijms24076463.
8
Janus Kinase Inhibitors: A New Tool for the Treatment of Axial Spondyloarthritis.Janus 激酶抑制剂:治疗中轴型脊柱关节炎的新工具。
Int J Mol Sci. 2023 Jan 5;24(2):1027. doi: 10.3390/ijms24021027.
9
Potential Therapeutic Mechanism of Scutellaria baicalensis Georgi against Ankylosing Spondylitis Based on a Comprehensive Pharmacological Model.基于综合药理学模型的黄芩治疗强直性脊柱炎的潜在治疗机制。
Biomed Res Int. 2022 Dec 21;2022:9887012. doi: 10.1155/2022/9887012. eCollection 2022.
10
The serum uric acid is longitudinally related to patients global assessment of disease activity in male patients with axial spondyloarthritis.血清尿酸与男性 axial spondyloarthritis 患者的疾病活动度的总体评估呈纵向相关。
BMC Musculoskelet Disord. 2022 Jul 27;23(1):717. doi: 10.1186/s12891-022-05657-3.